• Video
  • Shop
  • Culture
  • Family
  • Wellness
  • Food
  • Living
  • Style
  • Travel
  • News
  • Book Club
  • GMA3: WYNTK
  • Newsletter
  • Privacy Policy
  • Your US State Privacy Rights
  • Children's Online Privacy Policy
  • Interest-Based Ads
  • Terms of Use
  • Do Not Sell My Info
  • Contact Us
  • © 2025 ABC News
  • Wellness

Ozempic and Wegovy maker sues over compounded, off-brand versions of drugs used for weight loss

2:39
This is what happens when you stop taking Ozempic
Mario Tama/Getty Images
ByHaley Yamada
June 20, 2023, 11:07 PM

Novo Nordisk, the pharmaceutical company that makes Ozempic and Wegovy, filed multiple lawsuits Tuesday against off-brand versions of the wildly popular drugs.

In a press release, the company announced that legal action is being taken against certain medical spas, weight loss or wellness clinics, and compounding pharmacies for "the unlawful marketing and sales of non-FDA approved counterfeit and compounded semaglutide products claiming to contain semaglutide," including allegations of false advertising, trademark infringement and unlawful sales of non FDA-approved compounded products.

Boxes of the diabetes drug Ozempic rest on a pharmacy counter, Apr. 17, 2023, in Los Angeles.
Mario Tama/Getty Images

The new lawsuits follow recent safety warnings from federal regulators amid the rising popularity of semaglutide, the active ingredient in Ozempic and Wegovy, for weight loss.

Editor’s Picks

Woman says she got less costly drug for weight loss after being denied by insurance

  • May 18, 2023

People describe real-life side effects of popular injectable weight loss drugs

  • May 16, 2023

With growing popularity of new weight loss drugs, doctors emphasize potential risks

  • Jan 19, 2023

Without insurance coverage, the cost of medications like Ozempic and Wegovy can run more than $1,000 a month. Some people have reportedly turned to compounding pharmacies to combat those high prices, according to ABC News reporting.

Related Articles

MORE: FDA warns about safety of 'off-brand' versions of Ozempic, Wegovy

"Our priority is to ensure that patients have a safe and positive experience with our FDA-approved semaglutide medicines, and these actions are a direct reflection of that focus," Doug Langa, executive vice president of North America operations and president of Novo Nordisk, said in the press release announcing the lawsuit.

Related Articles

MORE: With Ozempic popularity on the rise, WW jumps into obesity drugs market

The U.S. Food and Drug Administration reported last month that it has received an unspecified number of reports of adverse events after people took injections of semaglutide that came from a compounding pharmacy, which the FDA defines as “the process of combining or mixing ingredients” to create a “tailored” medication.

"Patients should not use a compounded drug if an approved drug is available to treat a patient. Patients and health care professionals should understand that the agency does not review compounded versions of these drugs for safety, effectiveness, or quality," the FDA said in the safety warning.

Novo Nordisk also announced Tuesday it had launched a "resource hub" in the U.S. to provide information on semaglutide, including how to spot a "counterfeit injectable product."

"We believe it's important to provide additional tools and education to support the proper use of our approved semaglutide products and create broad public awareness regarding the difference between our FDA-approved medicines and other products being labeled as semaglutide," Langa said Tuesday.

ABC News' Katie Kindelan and Nicole Wetsman contributed to this report.

Editor’s Picks

Woman says she got less costly drug for weight loss after being denied by insurance

  • May 18, 2023

People describe real-life side effects of popular injectable weight loss drugs

  • May 16, 2023

With growing popularity of new weight loss drugs, doctors emphasize potential risks

  • Jan 19, 2023

Up Next in Wellness—

Weight-loss meds may give people more control over drinking, study shows

May 9, 2025

3 Doors Down frontman announces Stage 4 cancer diagnosis

May 8, 2025

Women's Health Initiative to continue after threat of funding cuts, researchers say

May 7, 2025

Try this doctor-approved smoothie for energy, immunity and heart health

May 1, 2025

Shop GMA Favorites

ABC will receive a commission for purchases made through these links.

Sponsored Content by Taboola

The latest lifestyle and entertainment news and inspiration for how to live your best life - all from Good Morning America.
  • Contests
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Info
  • Children’s Online Privacy Policy
  • Advertise with us
  • Your US State Privacy Rights
  • Interest-Based Ads
  • About Nielsen Measurement
  • Press
  • Feedback
  • Shop FAQs
  • ABC News
  • ABC
  • All Videos
  • All Topics
  • Sitemap

© 2025 ABC News
  • Privacy Policy— 
  • Your US State Privacy Rights— 
  • Children's Online Privacy Policy— 
  • Interest-Based Ads— 
  • Terms of Use— 
  • Do Not Sell My Info— 
  • Contact Us— 

© 2025 ABC News